ID:SP100_HUMAN DESCRIPTION: RecName: Full=Nuclear autoantigen Sp-100; AltName: Full=Lysp100b; AltName: Full=Nuclear dot-associated Sp100 protein; AltName: Full=Speckled 100 kDa; FUNCTION: May play a role in the control of gene expression. SUBUNIT: Homodimer. Splice variants heterodimerize. Interacts with members of the HP1 family of nonhistone chromosomal protein, such as CBX5 and CBX3 via the PxVxL motif. Interacts with Epstein-Barr virus EBNA-LP. Interacts with human cytomegalovirus/HHV-5 protein UL123. INTERACTION: P55854:SUMO3; NbExp=2; IntAct=EBI-751145, EBI-474067; SUBCELLULAR LOCATION: Nucleus, PML body. Note=Found in the nuclear body, also known as nuclear domain 10 (ND10), PML oncogenic domain (POD), nuclear dots (ND) and KR body. The nuclear body is a nucleoplasmic structure of punctate shape, which varies in size and number. Induction by interferon and may be cell cycle stages modulate the subnuclear localization of the isoforms. TISSUE SPECIFICITY: Widely expressed. Sp100-B is expressed only in spleen, tonsil, thymus, mature B-cell line and some T-cell line, but not in brain, liver, muscle or non-lymphoid cell lines. INDUCTION: By interferon. DOMAIN: The HSR domain is important for the nuclear body targeting as well as for the dimerization. DOMAIN: Contains one Pro-Xaa-Val-Xaa-Leu (PxVxL) motif, which is required for interaction with chromoshadow domains. This motif requires additional residues -7, -6, +4 and +5 of the central Val which contact the chromoshadow domain. PTM: Sumoylated. Sumoylation depends on a functional nuclear localization signal but is not necessary for nuclear import or nuclear body targeting. MISCELLANEOUS: The major isoform Sp100-A, has a calculated MW of 54 kDa, but exhibits aberrant electrophoretic mobilities, with an apparent MW OF 100 kDa. SIMILARITY: Contains 2 HMG box DNA-binding domains. SIMILARITY: Contains 1 HSR domain. SIMILARITY: Contains 1 SAND domain.
The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.
ModBase Predicted Comparative 3D Structure on P23497
Front
Top
Side
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.
Orthologous Genes in Other Species
Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
Gene Ontology (GO) Annotations with Structured Vocabulary
Molecular Function: GO:0000981 RNA polymerase II transcription factor activity, sequence-specific DNA binding GO:0003677 DNA binding GO:0003713 transcription coactivator activity GO:0003714 transcription corepressor activity GO:0005515 protein binding GO:0008134 transcription factor binding GO:0019900 kinase binding GO:0019904 protein domain specific binding GO:0042802 identical protein binding GO:0042803 protein homodimerization activity GO:0070087 chromo shadow domain binding
Biological Process: GO:0000122 negative regulation of transcription from RNA polymerase II promoter GO:0000723 telomere maintenance GO:0006351 transcription, DNA-templated GO:0006355 regulation of transcription, DNA-templated GO:0006978 DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator GO:0010596 negative regulation of endothelial cell migration GO:0016032 viral process GO:0032526 response to retinoic acid GO:0032897 negative regulation of viral transcription GO:0034097 response to cytokine GO:0034340 response to type I interferon GO:0034341 response to interferon-gamma GO:0043392 negative regulation of DNA binding GO:0043433 negative regulation of sequence-specific DNA binding transcription factor activity GO:0045185 maintenance of protein location GO:0045765 regulation of angiogenesis GO:0045892 negative regulation of transcription, DNA-templated GO:0045893 positive regulation of transcription, DNA-templated GO:0046826 negative regulation of protein export from nucleus GO:0048384 retinoic acid receptor signaling pathway GO:0051091 positive regulation of sequence-specific DNA binding transcription factor activity GO:0051271 negative regulation of cellular component movement GO:0060333 interferon-gamma-mediated signaling pathway GO:0060337 type I interferon signaling pathway GO:1902041 regulation of extrinsic apoptotic signaling pathway via death domain receptors GO:1902044 regulation of Fas signaling pathway GO:1903507 negative regulation of nucleic acid-templated transcription